Related Experiment Videos
New Data on the Methohexital-Thiopental-Arrhythmia Issue.
Chester Pearlman1, Janet Richmond
1Boston VA Medical Center and the Department of Psychiatry, Tufts University School of Medicine, Boston, Massachusetts, USA.
Convulsive Therapy
|January 1, 1990
Summary
Thiopental and methohexital anesthesia for electroconvulsive therapy (ECT) showed similar low rates of arrhythmias. Postictal hyperventilation appears crucial in preventing hypercapnia and related cardiac events during ECT.
Area of Science:
- Anesthesiology
- Neurology
- Cardiology
Background:
- Previous studies suggested thiopental anesthesia for electroconvulsive therapy (ECT) leads to higher arrhythmia incidence than methohexital.
- The role of hypercapnia in ECT-associated arrhythmias requires further investigation.
Purpose of the Study:
- To re-examine the incidence of arrhythmias with thiopental versus methohexital during electroconvulsive therapy (ECT).
- To reconsider the potential contribution of hypercapnia to arrhythmias in ECT patients.
Main Methods:
- A retrospective review of 50 electroconvulsive therapy (ECT) treatments for each anesthetic agent (thiopental and methohexital).
- Analysis of arrhythmia occurrences in 13 patients who received both anesthetic agents.
Main Results:
- Only one brief episode of arrhythmia was observed across all 100 treatments.
- This finding contrasts with previous reports suggesting a higher incidence with thiopental.
Conclusions:
- The incidence of arrhythmias during ECT appears low and comparable between thiopental and methohexital.
- Effective postictal hyperventilation may prevent hypercapnia and mitigate associated arrhythmias in ECT patients.